Geriatric syndromes: new frontiers in HIV and sarcopenia

Kellie L Hawkins1, Todd T Brown, Joseph B Margolick

  • 1aUniversity of Colorado, Aurora, Colorado bJohns Hopkins School of Medicine cJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Insights

Older adults with HIV experience accelerated aging and geriatric syndromes like sarcopenia. Early recognition and prevention are crucial for managing these age-related conditions in HIV patients.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Public Health

Background:

  • Combination antiretroviral therapy (ART) has transformed HIV infection into a manageable chronic condition, increasing life expectancy for patients.
  • As HIV-positive individuals age, the long-term effects of chronic infection and its management on health are becoming a significant research area.
  • People living with HIV often experience earlier onset of aging-related conditions compared to HIV-negative individuals due to comorbidities, lifestyle factors, chronic inflammation, and ART.

Purpose of the Study:

  • This review focuses on sarcopenia, a key geriatric syndrome, in aging populations with HIV.
  • It examines the relationship between sarcopenia, frailty, and falls in this demographic.
  • The review highlights the roles of HIV, ART, and comorbidities in these aging syndromes and emphasizes early detection and prevention strategies.

Main Methods:

  • This is a review article, synthesizing existing research on aging syndromes in HIV-infected populations.
  • It analyzes the contribution of HIV infection, antiretroviral therapy (ART), and comorbidities to the development of geriatric syndromes.
  • The focus is on sarcopenia, frailty, and falls in older adults living with HIV.

Main Results:

  • People living with HIV show an earlier onset of aging-related conditions and geriatric syndromes.
  • Sarcopenia, frailty, and falls are significant concerns in older HIV-infected individuals.
  • Chronic inflammation, comorbidities, and ART-related factors contribute to accelerated aging in this population.

Conclusions:

  • HIV-infected individuals are at higher risk for premature aging and associated geriatric syndromes like sarcopenia.
  • Understanding the interplay of HIV, ART, and comorbidities is essential for addressing these age-related issues.
  • Early identification and proactive management of sarcopenia and related syndromes are critical for improving health outcomes in aging HIV populations.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
303
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288